Re:When Dying Patients Want Unproven Drugs
by mitthrowaway2 on Wednesday June 21, 2023 @02:01AM
(#36414937)
Then all you get is data about the effectiveness of XY. Would it be any better if only X was tested, but it turned out that that one drug 'X' contained two separate active ingredients, each of which the pharmaceutical company thought would probably be an effective treatment?
Also: I can imagine that most of the patients would be eager to engage in all possible treatments. You might not even have a control group that did not participate in the study of the faulty drug X